Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07747467
What this trial is testing

Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT02647281
What this trial is testing

First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects

Who this might be right for
Hepatitis B
GlaxoSmithKline 56
Testing effectiveness (Phase 2)Ended earlyNCT06677307
What this trial is testing

A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110

Who this might be right for
Alpha-1 Anti-trypsin DeficiencyAATD
Korro Bio, Inc. 42
Testing effectiveness (Phase 2)Study completedNCT03517540
What this trial is testing

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 193
Very early researchUnknownNCT06054984
What this trial is testing

TCR-T Cells in the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00559247
What this trial is testing

A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 24
Early research (Phase 1)Study completedNCT02618187
What this trial is testing

Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Seres Therapeutics, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT04778904
What this trial is testing

First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV

Who this might be right for
Hepatitis B
Barinthus Biotherapeutics 55
Early research (Phase 1)Study completedNCT05638347
What this trial is testing

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

Who this might be right for
Inflammatory Bowel Disease
Atridia Pty Ltd. 16
Early research (Phase 1)Study completedNCT02655952
What this trial is testing

Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients

Who this might be right for
Metastatic Breast CancerMetastatic Colon CancerMetastatic Prostate Cancer
WntResearch AB 17
Testing effectiveness (Phase 2)Study completedNCT03748199
What this trial is testing

Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CF

Who this might be right for
Cystic Fibrosis
Santhera Pharmaceuticals 32
Post-approval studies (Phase 4)UnknownNCT01105611
What this trial is testing

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Who this might be right for
HIV InfectionsHepatitis C
St. James's Hospital, Ireland 40
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT02279433
What this trial is testing

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

Who this might be right for
Solid Tumors
Nuvation Bio Inc. 46
Early research (Phase 1)Ended earlyNCT01164904
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 72
Early research (Phase 1)Study completedNCT01298063
What this trial is testing

Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 35
Early research (Phase 1)Study completedNCT03486990
What this trial is testing

Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

Who this might be right for
Celiac Disease
Takeda 23
Early research (Phase 1)Study completedNCT03980080
What this trial is testing

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects

Who this might be right for
Healthy Subjects
OSE Immunotherapeutics 63
Large-scale testing (Phase 3)UnknownNCT00008489
What this trial is testing

Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults

Who this might be right for
HIV Infections
PharmaResearch 200
Early research (Phase 1)Study completedNCT00441376
What this trial is testing

ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver

Who this might be right for
Hepatocellular CarcinomaLiver Neoplasms
Imunon 30
Next Page